Encompass Health Corporation $EHC Stock Bought by William Blair Investment Management LLC

William Blair Investment Management LLC increased its holdings in Encompass Health Corporation (NYSE:EHC – Free Report) by 1.3% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 1,166,552 shares of the company’s stock after purchasing an additional 15,467 shares during the period. William Blair Investment Management LLC’s holdings in Encompass Health were worth $141,724,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of the business. Allworth Financial LP boosted its holdings in shares of Encompass Health by 10.3% during the 3rd quarter. Allworth Financial LP now owns 1,366 shares of the company’s stock valued at $166,000 after acquiring an additional 127 shares during the last quarter. Russell Investments Group Ltd. grew its stake in shares of Encompass Health by 6.5% in the third quarter. Russell Investments Group Ltd. now owns 108,357 shares of the company’s stock worth $13,165,000 after acquiring an additional 6,588 shares during the period. Maryland State Retirement & Pension System grew its stake in shares of Encompass Health by 26.9% in the third quarter. Maryland State Retirement & Pension System now owns 6,554 shares of the company’s stock worth $796,000 after acquiring an additional 1,390 shares during the period. Jefferies Financial Group Inc. raised its holdings in shares of Encompass Health by 114.9% during the third quarter. Jefferies Financial Group Inc. now owns 14,684 shares of the company’s stock valued at $1,784,000 after purchasing an additional 7,852 shares during the last quarter. Finally, Bahl & Gaynor LLC raised its holdings in shares of Encompass Health by 25.0% during the third quarter. Bahl & Gaynor LLC now owns 921,908 shares of the company’s stock valued at $112,003,000 after purchasing an additional 184,230 shares during the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Wall Street Analyst Weigh In

EHC has been the topic of a number of research analyst reports. Barclays increased their price objective on shares of Encompass Health from $144.00 to $151.00 and gave the company an “overweight” rating in a research report on Thursday, October 29th. Truist Financial reaffirmed a “buy” rating and issued a $156.00 target price (up from $150.00) on shares of Encompass Health in a research report on Friday, October 30th. Raymond James Financial reiterated a “strong-buy” rating and set a $155.00 target price on shares of Encompass Health in a research note on Friday, October 30th. KeyCorp increased their price target on Encompass Health from $147.00 to $150.00 and gave the company an “overweight” rating in a report on Friday, October 30th. Finally, UBS Group increased their price target on Encompass Health from $155.00 to $165.00 and gave the company a “buy” rating in a report on Friday, October 30th. One research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and one has issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy” and a consensus target price of $154.25.

Get Our Latest Report on EHC

Encompass Health Trading Down 0.1%

Shares of Encompass Health stock opened at $140.86 on Monday. Encompass Health Corporation has a 1-year low of $92.77 and a 1-year high of $143.90. The company’s fifty day simple moving average is $126.70 and its 200-day simple moving average is $112.02. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.09 and a quick ratio of 1.09. The stock has a market capitalization of $13.82 billion, a PE ratio of 22.01, a P/E/G ratio of 2.44 and a beta of 0.83.

Encompass Health (NYSE:EHC – Get Free Report) last posted its quarterly earnings data on Wednesday, October 28th. The company reported $1.52 EPS for the quarter, topping the consensus estimate of $1.36 by $0.16. Encompass Health had a return on equity of 18.35% and a net margin of 10.17%. The firm had revenue of $1.61 billion during the quarter, compared to analyst estimates of $1.60 billion. During the same period in the prior year, the business posted $1.23 EPS. Encompass Health’s revenue was up 8.9% on a year-over-year basis. As a group, equities analysts anticipate that Encompass Health Corporation will post 6.29 earnings per share for the current year.

Encompass Health Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, January 15th. Shareholders of record on Monday, January 4th will be issued a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a yield of 0.6%. The ex-dividend date of this dividend is Monday, January 4th. Encompass Health’s payout ratio is currently 13.12%.

Insider Buying and Selling

In other Encompass Health news, EVP John Darby sold 4,858 shares of the company’s stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $121.09, for a total value of $588,255.22. Following the completion of the sale, the executive vice president owned 75,041 shares in the company, valued at $9,086,714.69. This represents a 6.08% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. 1.80% of the stock is currently owned by insiders.

Encompass Health Company Profile

(Free Report)

Encompass Health Corporation is a U.S. healthcare provider focused on inpatient rehabilitation. The company operates rehabilitation hospitals that offer specialized care for people recovering from conditions such as strokes, brain and spinal cord injuries, orthopedic conditions, and other illnesses or injuries. Its hospitals provide coordinated rehabilitation services, including physical, occupational, and speech therapy, alongside medical care. Encompass Health serves patients through facilities across the United States.

Featured Stories

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHC – Free Report).

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.